D. Hedrich

发表

Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

A. Pharris, T. Rhodes, M. Salminen, 2014, The International journal on drug policy.

Harm Reduction: Evidence, Impacts and Challenges

T. Rhodes, D. Hedrich, 2010 .

Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries.

L. Tavoschi, P. Lopalco, S. Babudieri, 2019, Vaccine.

Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe?

A. Pharris, M. J. van de Laar, V. Hope, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Prevention and control of infectious diseases among people who inject drugs

A. Pharris, M. Salminen, D. Hedrich, 2011 .

Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area

L. Tavoschi, S. Babudieri, R. Monarca, 2018, Epidemiologic reviews.

A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA

L. Tavoschi, H. Wolff, S. Babudieri, 2018, Journal of viral hepatitis.

Ten Years of Monitoring Illicit Drug Use in Prison Populations in Europe: Issues and Challenges

D. Hedrich, L. Royuela, André Noor, 2012 .

D. Hedrich, 2015 .

Challenges and opportunities for the management of infectious diseases in Europes' prisons: evidence-based guidance.

L. Tavoschi, D. Hedrich, É. O'Moore, 2019, The Lancet. Infectious diseases.

Continued signs of resilience in the European drug market: Highlights from the EMCDDA’s 2016 European drug report

M. Ferri, P. Griffiths, D. Hedrich, 2016 .

Surveillance and outbreak reports

V. Hutse, R. Chalmers, K. Elwin, 2009 .

The effectiveness of opioid maintenance treatment in prison settings: a systematic review.

L. Møller, D. Hedrich, S. Mayet, 2012, Addiction.

Lessons learned from the first European project on the integration of infectious diseases in testing services, data collection and country responses

J. Lazarus, A. Sullivan, D. Raben, 2021, BMC Infectious Diseases.

A call to action toward integrated testing and earlier care for viral hepatitis, HIV, STIs and TB

B. Gazzard, J. Lazarus, J. Lundgren, 2020 .

Treatment of problem cocaine use – a short update

D. Hedrich, 2009 .

Balancing access to opioid substitution treatment with preventing the diversion of opioid substitution medications in Europe: challenges and implications

D. Hedrich, J. Mounteney, L. Montanari, 2021 .

From margin to mainstream: The evolution of harm reduction responses to problem drug use in Europe

D. Hedrich, L. Wiessing, A. Pirona, 2008 .

Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.

A. Nardone, P. Griffiths, D. Hedrich, 2009, American Journal of Public Health.

Drug consumption facilities in Europe and beyond

F. Dubois-Arber, T. Kerr, D. Hedrich, 2010 .

Drug consumption rooms: A systematic review of evaluation methodologies

T. Kerr, A. Ritter, M. Shanahan, 2019, Drug and alcohol review.

Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010.

M. J. van de Laar, D. Hedrich, L. Wiessing, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Systematic review on communicable diseases in prison settings

D. Hedrich, H. Vroling, A. Oordt, 2017 .

Harm Reduction Policies, Settings and Challenges

D. Hedrich, R. Hartnoll, 2015 .

European report on drug consumption rooms.

D. Hedrich, 2004 .

Harm-Reduction Interventions

D. Hedrich, R. Hartnoll, 2020, Textbook of Addiction Treatment.

Drug use and pregnancy - challenges for public health.

D. Hedrich, L. Wiessing, V. Gyarmathy, 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.

S. Polywka, M. Krausz, X. Castells, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe.

M. Ferri, Roland Simon, D. Hedrich, 2017, The International journal on drug policy.

Harm reduction and the mainstream

T. Rhodes, D. Hedrich, 2010 .

The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries

D. Hedrich, J. Mounteney, L. Montanari, 2019, Journal of studies on alcohol and drugs. Supplement.

Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011.

A. Pharris, M. Salminen, P. Griffiths, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Chapter 1 Harm reduction and the mainstream

T. Rhodes, D. Hedrich, Tim Rhodes, 2011 .

Opioid maintenance in European prisons: is the treatment gap closing?

M. Farrell, D. Hedrich, 2012, Addiction.

Drug consumption facilities: an update since 2000.

J. Kimber, K. Dolan, D. Hedrich, 2003, Drug and alcohol review.

F. Mathis, D. Hedrich, J. Vicente, 2017 .

Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions

D. Hedrich, E. Duffell, A. Mozalevskis, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Chapter 1 Harm Reduction and the Mainstream

T. Rhodes, D. Hedrich, 2022 .

Chapter 11 Drug consumption facilities in Europe and beyond

T. Kerr, D. Hedrich, 2011 .

Surveillance for hepatitis B virus infection in pregnant women in Greece shows high rates of chronic infection among immigrants 5 and low vaccination-induced protection rates: preliminary results of a single center study

H. Brokalaki, G. L., M. Forsgren, 2009 .

Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

A. Pharris, T. Rhodes, M. Salminen, 2014, The International journal on drug policy.

Treatment as prevention: will it work?

Attia, A. Pharris, A. Fotiou, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Rebound of overdose mortality in the European Union 2003-2005: findings from the 2008 EMCDDA Annual Report.

D. Hedrich, L. Wiessing, J. Vicente, 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.